Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Order: Signal: Tickers:
Overview Valuation Financial Ownership Performance Technical Custom Charts Tickers Quotes Basic TA News Snapshot
Total: 57 #1
TickerRNO [NYSE]
CompanyRhino Resource Partners LP
IndustryNonmetallic Mineral Mining
Market Cap142.49MEPS (ttm)-2.06
P/E-EPS this Y-58.20%
Forward P/E-EPS next Y51.70%
PEG-EPS past 5Y36.40%
P/S0.57EPS next 5Y-
P/B0.37EPS Q/Q-230.00%
Dividend36.33%Sales Q/Q-14.80%
Insider Own0.60%Inst Own45.50%
Insider Trans9.41%Inst Trans2.57%
Short Float0.41%EarningsJul 31/b
Analyst Recom2.30Target Price15.30
Avg Volume102.49K52W Range9.45 - 14.65
21-Oct-14 04:06PMThe 52-Week Low Club for Tuesday at 24/7 Wall St.
21-Oct-14 11:41AMWhy Rhino Resource Partners (RNO) Stock Is Slipping Today at TheStreet
21-Oct-14 10:14AMCoal Miner MLP Rhino Tumbles 56% After Cutting Dividend at Bloomberg
20-Oct-14 05:09PM5:09 pm Rhino Resource Partners announces Q3 distribution of $0.05 per unit, lowered from previous quarter distribution of $0.445 per unit; co redoubling its cost cutting efforts due to weak coal markets Briefing.com
20-Oct-14 04:01PMRHINO RESOURCE PARTNERS LP Files SEC form 8-K, Regulation FD Disclosure EDGAR Online
20-Oct-14 04:00PMRhino Resource Partners LP Announces Third Quarter Distribution and Earnings Release Date GlobeNewswire
10-Oct-14 04:22PMRHINO RESOURCE PARTNERS LP Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
02-Oct-14 05:50PMCan Renault Keep Dacia, Its Romanian Auto Brand, Cheap? at BusinessWeek
02-Oct-14 10:45AM[video] Renault launches new crossover Espace at CNNMoney.com
12-Sep-14 04:07PMRHINO RESOURCE PARTNERS LP Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
Rhino Resource Partners LP, together with its subsidiaries, produces, processes, and sells various grades of steam and metallurgical coal from surface and underground mines in the United States. As of December 31, 2013, it operated eight mines, including four underground and four surface mines located in Kentucky, Ohio, West Virginia, and Utah; and one underground mine in West Virginia through a joint venture. The company markets its steam coal primarily to electric utility companies as fuel for their steam powered generators; and metallurgical coal to steel and coke producers. It also manages and leases coal properties; owns and leases oil and gas mineral rights in the Cana Woodford region of western Oklahoma and Utica Shale region of eastern Ohio; mines and sells limestone from reserves located at Sands Hill mining complex to construction companies and road builders; and provides drill pad construction services for drilling operators. The company controlled an estimated 457.7 million tons of proven and probable coal reserves consisting of an estimated 438.0 million tons of steam coal and an estimated 19.7 million tons of metallurgical coal, as well as 277.0 million tons of non-reserve coal deposits. It also controlled an estimated 43.9 million tons of proven and probable coal reserves at the Rhino Eastern mining complex located in Central Appalachia through a joint venture. Rhino GP LLC operates as a general partner of the company. The company was founded in 2003 and is based in Lexington, Kentucky.
CompanyBlue Earth Inc.
IndustryPollution & Treatment Controls
Market Cap94.89MEPS (ttm)-0.58
P/E-EPS this Y-44.40%
Forward P/E-EPS next Y-
PEG-EPS past 5Y-37.30%
P/S8.63EPS next 5Y-
P/B1.01EPS Q/Q64.00%
Dividend-Sales Q/Q44.00%
Insider Own4.20%Inst Own0.50%
Insider Trans58.88%Inst Trans18.34%
Short Float1.86%Earnings-
Analyst Recom-Target Price-
Avg Volume350.61K52W Range1.75 - 3.93
21-Oct-14 05:19PMBlue Earth CEO Response to False Statements and Allegations Made by the Pump Stopper in Seeking Alpha Marketwired
21-Oct-14 04:09PMINVESTOR ALERT: Investigation of Blue Earth, Inc. Announced by Glancy Binkow & Goldberg LLP Business Wire
21-Oct-14 02:25PMMidday Losers From October 21: Blue Earth, Ocwen Financial, Chipotle And More Benzinga
29-Sep-14 09:15AMBlue Earth Launches Blue Earth Generator, Inc. to Provide Generator Services and Expand Its CHP Capabilities in the NYC Metropolitan, Northeast and Midwest Regions Marketwired
22-Sep-14 09:00AMSeeThruEquity Initiates Research Coverage on Blue Earth, Inc. with Target Price of $4.43 Accesswire
17-Sep-14 10:55AMBlue Earth to Invest $10 Million in Battery Producer at Bloomberg
17-Sep-14 09:15AMBlue Earth to Purchase Equity Position in PowerGenix With $10 Million Dollar Investment Marketwired
11-Sep-14 06:01AMBLUE EARTH, INC. Files SEC form 8-K, Financial Statements and Exhibits EDGAR Online
08-Sep-14 09:15AMBlue Earth and DCO Energy, LLC to Build $17.4 Million Central Energy Center for a New Hotel and Casino in Las Vegas, Nevada Marketwired
08-Sep-14 09:05AMSeeThruEquity Announces Fall Microcap Investor Conference To Be Held On September 11th, 2014 Accesswire
Blue Earth, Inc., together with its subsidiaries, provides energy efficiency and alternative/renewable energy solutions for small and medium sized commercial and industrial facilities. It also owns, manages, and operates independent power generation systems; and engineers, develops, constructs, operates, and maintains small and medium scale alternative/renewable energy power plants, including solar photovoltaic, combined heat and power, or on-site cogeneration and fuel cells. In addition, the company manufactures, sells, and installs commercial refrigeration gaskets and strip curtains, as well as sells and installs other energy efficiency products, such as EC motors, LED lights, and various control technologies. Further, it offers a range of energy solutions comprising specialized mechanical engineering, design, construction, and implementation of energy savings projects; energy conservation; energy infrastructure outsourcing; power generation; and energy supply and risk management. Additionally, the company provides maintenance and service programs, including heating, ventilation and air-conditioning (HVAC); and mechanical systems for design-build to repair and retrofit services, as well as finances alternative and renewable energy projects through industry relationships. It has strategic relationship with Kenyon Energy. Blue Earth, Inc. was founded in 2007 and is headquartered in Henderson, Nevada.
CompanyiBio, Inc.
Market Cap117.36MEPS (ttm)-0.06
P/E-EPS this Y53.80%
Forward P/E-EPS next Y-
PEG-EPS past 5Y7.80%
P/S586.82EPS next 5Y-
P/B19.33EPS Q/Q0.00%
Dividend-Sales Q/Q-66.70%
Insider Own45.02%Inst Own2.00%
Insider Trans-0.46%Inst Trans-1.46%
Short Float0.26%Earnings-
Analyst Recom2.00Target Price3.00
Avg Volume4.04M52W Range0.24 - 3.48
21-Oct-14 06:21PMA Look at Oil Refiners, Ebola Fighters at Barrons.com
21-Oct-14 06:10AMEbola Stocks May Be Overpriced as Fundamentals Outweigh Fear at TheStreet
20-Oct-14 10:45AMWhy iBio (IBIO) Stock Is Plummeting Today at TheStreet
17-Oct-14 10:33AMWhy iBio (IBIO) Stock Continues to Soar Today at TheStreet
16-Oct-14 04:05PMTwo biotechs staking claim in fight against Ebola at MarketWatch
16-Oct-14 02:05PMEbola Stocks on the Move at 24/7 Wall St.
16-Oct-14 09:58AMWhy iBio (IBIO) Stock Is Soaring Today at TheStreet
16-Oct-14 08:51AMIBio shares surge after company responds to inquiries regarding Ebola outbreak at MarketWatch
16-Oct-14 08:31AMiBio Responds to Inquiries About its Role in Emergency Response to Ebola Virus Disease Outbreak Marketwired
15-Oct-14 12:51PMCould Sinovac Biotech Be The Next Ebola Play? Benzinga
iBio, Inc., a biotechnology company, focuses on the commercialization of its proprietary plant-based protein expression technologies in the United States and internationally. Its proprietary technologies include iBioLaunch, a transformative platform technology for the development and production of therapeutic proteins and vaccines; and iBioModulator, a technology platform that enhances the potency and duration of the effect of prophylactic and therapeutic vaccines. The company's product candidates comprise IBIO-CFB03, a product for treatment of idiopathic pulmonary fibrosis; C1 Esterase Inhibitor, a plasma-derived protein; Alpha-Galactosidase, an enzyme replacement protein; and Palivizumab, a monoclonal antibody for the therapeutic protein market. Its vaccine products include H1N1 Influenza and H5N1 Influenza products that have completed Phase I human clinical trials, as well as yellow fever vaccine; malaria and hookworm parasitic pathogen vaccines; and human papillomavirus therapeutic vaccine. The company's product candidates also comprise Anthrax/Plague bacterial disease vaccine; and Anthrax, a monoclonal antibody for the biodefense market. It has strategic alliances and collaborations with various companies, such as Fraunhofer Center for Molecular Biology, GE Healthcare, FioCruz, and Caliber Biotherapeutics LLC. The company is headquartered in Newark, Delaware.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DESANTIS CARL10% OwnerSep 17Sale0.7655,70042,3325,751,143Sep 18 05:11 PM
DESANTIS CARL10% OwnerSep 16Sale0.6329,88018,8245,806,843Sep 18 05:11 PM
DESANTIS CARL10% OwnerSep 15Sale0.6053,13031,8785,836,723Sep 18 05:11 PM
DESANTIS CARL10% OwnerFeb 03Sale0.5528,82815,8555,889,853Feb 04 06:28 PM
DESANTIS CARL10% OwnerJan 31Sale0.5654,88930,7385,949,314Jan 31 05:13 PM
CompanyMagnegas Corporation
IndustryMajor Integrated Oil & Gas
Market Cap34.89MEPS (ttm)-0.25
P/E-EPS this Y29.30%
Forward P/E-EPS next Y-
PEG-EPS past 5Y-15.70%
P/S31.72EPS next 5Y-
P/B2.33EPS Q/Q28.60%
Dividend-Sales Q/Q100.00%
Insider Own1.40%Inst Own6.40%
Insider Trans32.46%Inst Trans199.38%
Short Float5.85%EarningsNov 11
Analyst Recom2.00Target Price0.95
Avg Volume689.68K52W Range0.40 - 2.45
21-Oct-14 09:24AMMAGNEGAS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, EDGAR Online
21-Oct-14 09:18AM9:18 am Magnegas has entered into definitive agreements with an institutional investor for a financing of $5 million in total gross proceeds Briefing.com
21-Oct-14 09:16AMMagneGas Corporation Enters Into Definitive Agreements for Financing of $5 Million in Gross Proceeds PR Newswire
17-Oct-14 01:34PMMAGNEGAS CORP Files SEC form 8-K/A, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S EDGAR Online
14-Oct-14 08:00AMMAGNEGAS CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
14-Oct-14 08:00AMMagneGas Signs Agreement to Treat Medical and Pharmaceutical Waste PR Newswire
09-Oct-14 09:15AMMagneGas Joint Venture Partner Files Comprehensive Co-Combustion Patent PR Newswire
09-Oct-14 09:15AMNew Technology Reduces Coal Power Emissions to Natural Gas Levels and Reduces CO2 By Up To 40% PR Newswire
09-Oct-14 06:00AMMAGNEGAS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits EDGAR Online
07-Oct-14 10:52AMMagneGas Hires Vice President of Engineering to Oversee Growing Development Initiatives PR Newswire
MagneGas Corporation, an alternative energy company, hydrogen based alternative fuel through the gasification of carbon-rich liquids in the United States and internationally. The company produces and distributes gas bottled in cylinders to the metalworking market as an alternative to acetylene. It offers MagneGas, a fuel that primarily comprises hydrogen; and Plasma Arc Flow refineries that produce gas. The company also sells and licenses the plasma arc technology for the processing of liquid waste. The company was founded in 2007 and is headquartered in Tarpon Springs, Florida.
TickerOCN [NYSE]
CompanyOcwen Financial Corp.
IndustryMortgage Investment
Market Cap2.81BEPS (ttm)2.21
P/E9.72EPS this Y62.60%
Forward P/E6.45EPS next Y40.27%
PEG0.38EPS past 5Y48.00%
P/S1.28EPS next 5Y25.80%
P/B1.55EPS Q/Q6.70%
Dividend-Sales Q/Q1.50%
Insider Own0.30%Inst Own85.10%
Insider Trans6.23%Inst Trans-5.31%
Short Float9.93%EarningsOct 30/b
Analyst Recom2.30Target Price33.56
Avg Volume2.68M52W Range22.75 - 60.18
22-Oct-14 03:00AMOcwen's Backdated Letters May Violate Consent Order at Bloomberg
22-Oct-14 02:03AM[$$] Ocwen Accused Anew of Improper Practices at The Wall Street Journal
21-Oct-14 10:02PMOcwen Financial Corporation -- Moody's downgrades Ocwen, Altisource Solutions, and HLSS' ratings at Moody's
21-Oct-14 06:08PMNY says Ocwen backdated foreclosure letters, company shares slide Reuters
21-Oct-14 05:12PMTop mortgage firm accused of abuses AP
21-Oct-14 04:40PMOcwen Corrects Earlier Statement in Response to Letter From New York Department of Financial Services GlobeNewswire
21-Oct-14 04:06PMThe 52-Week Low Club for Tuesday at 24/7 Wall St.
21-Oct-14 03:26PMBlock & Leviton LLP Investigates Ocwen Financial Corporation After Announcement That New York Regulators Are Investigating Improper Backdating Of Loan Modification Letters PR Newswire
21-Oct-14 03:05PMOcwen's Stock Tumbles On New York Regulator Backdating Accusations at Forbes
21-Oct-14 02:47PMWhy Ocwen Financial (OCN) Stock Hit a One-Year Low Today at TheStreet
Ocwen Financial Corporation, through its subsidiaries, is engaged in the servicing and origination of mortgage loans in the United States and internationally. The company's Servicing segment provides residential and commercial mortgage loan servicing, special servicing, and asset management services to owners of mortgage loans and foreclosed real estate. This segments residential servicing portfolio includes conventional; government insured; and non-agency loans, such as subprime loans. Ocwen Financial Corporation's Lending segment is involved in originating and purchasing conventional and government insured residential forward, and reverse mortgage loans primarily through its correspondent lending arrangements, as well as offers direct lending services. The company was founded in 1988 and is headquartered in Atlanta, Georgia.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ROSS WILBUR L JRDirectorJul 14Sale37.001,950,29672,160,9520Jul 15 05:15 PM
WISH BARRY NDirectorNov 21Sale53.4166,3263,542,5383,913,621Nov 22 02:47 PM
WISH BARRY NDirectorNov 20Sale53.57183,6749,838,7923,979,947Nov 22 02:47 PM
Hayes Timothy M.EVP, Gen. Counsel & SecretaryNov 18Buy52.441,00052,4401,000Nov 19 02:32 PM
ERBEY WILLIAM CExecutive ChairmanNov 05Option Exercise5.9263,679376,7829,983,995Nov 07 05:28 PM
TickerESI [NYSE]
CompanyITT Educational Services Inc.
IndustryEducation & Training Services
Market Cap252.09MEPS (ttm)2.52
P/E4.27EPS this Y-56.90%
Forward P/E4.19EPS next Y-5.98%
PEG5.69EPS past 5Y-13.30%
P/S0.24EPS next 5Y0.75%
P/B1.24EPS Q/Q-19.50%
Dividend-Sales Q/Q-12.60%
Insider Own1.70%Inst Own-
Insider Trans44.10%Inst Trans-0.28%
Short Float60.66%EarningsOct 17/b
Analyst Recom2.60Target Price13.00
Avg Volume1.59M52W Range3.66 - 45.80
21-Oct-14 06:02PMNYSE stocks posting largest percentage decreases AP
21-Oct-14 02:25PMMidday Losers From October 21: Blue Earth, Ocwen Financial, Chipotle And More Benzinga
21-Oct-14 11:06AMPerilous Reversal Stock: ITT Educational Services (ESI) at TheStreet
21-Oct-14 07:27AMITT Educational Services (ESI) Soars: Stock Adds 38% Zacks
20-Oct-14 05:19PMITT EDUCATIONAL SERVICES INC Files SEC form 10-K/A, Annual Report EDGAR Online
20-Oct-14 04:35PMITT Educational Up 65% on Q2, Q3 Operational Update Zacks
20-Oct-14 12:13PMWhy ITT Educational Services (ESI) Stock is Up Today at TheStreet
20-Oct-14 08:58AMUPDATE: Bank Of America Reiterates On ITT Educational Services As Shares Surge But Risks Remain Benzinga
17-Oct-14 01:51PMITT enrollment falls less than feared, stock soars AP
17-Oct-14 01:30PM[$$] ITT Enrollment Not As Bad As Feared at The Wall Street Journal
ITT Educational Services, Inc. provides postsecondary degree programs in the United States. It offers master, bachelor, and associate degree programs to approximately 57,000 students, as well as short-term information technology and business learning solutions for career advancers and other professionals. The company's information technology programs include communications, network administration, network technology, software development, systems technology, and technical support; and electronics technology programs comprise communications, computer technology, electronics product design and fabrication, industrial electronics, instrumentation, and telecommunications. Its drafting and design programs consist of architectural and construction drafting, civil drafting, computer aided drafting, electrical and electronics drafting, interior design, landscape architecture, mechanical drafting, and multimedia communications; business programs comprise accounting, business administration, financial services, manufacturing, marketing and advertising, and sales; and criminal justice programs include corrections, cyber security, investigations, and security and policing. The company's nursing and health sciences programs comprise health information technology, medical assisting and administration, and nursing. As of December 31, 2013, it had 149 college locations, including 147 campuses and 2 learning sites in 39 states, and 1 training facility, as well as online programs to students who are located in 50 states. The company was founded in 1946 and is headquartered in Carmel, Indiana.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MCCORMACK JUNE MEVP & President Online DivFeb 24Sale34.2975725,95821,490Feb 25 02:54 PM
TANNER GLENN EEVP, Chief Marketing OfficerFeb 18Sale32.5379325,79316,433Feb 20 10:05 AM
TANNER GLENN EEVP, Chief Marketing OfficerJan 29Sale38.871,84771,79413,096Jan 31 09:41 AM
MCCORMACK JUNE MEVP & President Online DivJan 24Sale43.6775733,05819,159Jan 28 04:08 PM
MCCORMACK JUNE MEVP & President Online DivDec 23Sale35.0075726,49519,916Dec 31 12:12 PM
CompanySinoCoking Coal and Coke Chemical Industries, Inc.
IndustryNonmetallic Mineral Mining
Market Cap78.11MEPS (ttm)0.05
P/E65.20EPS this Y0.00%
Forward P/E-EPS next Y-
PEG-EPS past 5Y-62.40%
P/S1.55EPS next 5Y-
P/B0.53EPS Q/Q0.00%
Dividend-Sales Q/Q-38.60%
Insider Own31.69%Inst Own0.40%
Insider Trans-Inst Trans179.74%
Short Float4.43%EarningsMay 14
Analyst Recom3.00Target Price-
Avg Volume2.63M52W Range0.83 - 9.37
21-Oct-14 10:47AMPerilous Reversal Watch: Sinocoking Coal And Coke Chemicals (SCOK) at TheStreet
20-Oct-14 04:24PMAfter weeks of volatile trading, major averages move steadily higher Yahoo Finance Blogs
20-Oct-14 01:15PMMidday Gainers From October 20: SinoCoking Coal Up 70%, ITT And Sears Also Rise Benzinga
20-Oct-14 10:12AMWhy SinoCoking Coal and Coke Chemical (SCOK) Stock Is Up Today at TheStreet
20-Oct-14 10:02AMSinocoking Coal And Coke Chemicals (SCOK) Strong On High Relative Volume Today at TheStreet
20-Oct-14 06:47AMSinoCoking Aboveground Syngas Facility Commences Operations GlobeNewswire
14-Oct-14 04:05PMSINOCOKING COAL & COKE CHEMICAL INDUSTRIES, INC. Files SEC form 8-K, Other Events EDGAR Online
08-Oct-14 10:42AMSinoCoking Up As Synthetic Gas Project Moves Forward at Investor's Business Daily
08-Oct-14 07:30AMSinoCoking Issues Update on Construction and Financing of Underground Syngas Project GlobeNewswire
04-Oct-14 01:04PMSINOCOKING COAL & COKE CHEMICAL INDUSTRIES, INC. Financials EDGAR Online Financials
SinoCoking Coal and Coke Chemical Industries, Inc. operates as a coal and coke producer in the People's Republic of China. Its products include raw coal, washed coal, medium or mid-coal, coal slurries, coke, coal tar, and crude benzol. The company also provides metallurgical coke for steel manufacturing. In addition, it engages in coal trading activities. The company was founded in 1996 and is based in Pingdingshan, the People's Republic of China.
CompanyOmeros Corporation
Market Cap411.96MEPS (ttm)-1.59
P/E-EPS this Y12.60%
Forward P/E-EPS next Y60.60%
PEG-EPS past 5Y30.00%
P/S823.92EPS next 5Y-
P/B-EPS Q/Q-10.40%
Dividend-Sales Q/Q-67.90%
Insider Own5.60%Inst Own41.70%
Insider Trans1.06%Inst Trans-0.60%
Short Float21.18%EarningsAug 11
Analyst Recom1.70Target Price32.80
Avg Volume294.35K52W Range6.92 - 18.80
21-Oct-14 08:23AMOmeros suspends mid-stage trial of Huntington's drug, shares fall Reuters
21-Oct-14 07:03AM7:03 am Omeros provides update on PDE10 inhibitor program; enrollment in Huntington's Trial suspended pending further assessment of preclinical data Briefing.com
21-Oct-14 07:00AMOmeros Provides Update on PDE10 Inhibitor Program PR Newswire
07-Oct-14 07:00AMOMEROS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement EDGAR Online
29-Sep-14 04:46PMOMEROS CORP Files SEC form 8-K, Material Modification to Rights of Security Holders, Financial Statements and Exhibit EDGAR Online
15-Sep-14 06:57AMIncreased Earnings Estimates Seen for Omeros Corporation (OMER): Can It Move Higher? Zacks
19-Aug-14 01:04PMOMEROS CORP Financials EDGAR Online Financials
11-Aug-14 04:10PMOMEROS CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
11-Aug-14 04:03PMOMEROS CORP Files SEC form 10-Q, Quarterly Report EDGAR Online
11-Aug-14 04:03PMOmeros Corporation Reports Second Quarter 2014 Financial Results PR Newswire
Omeros Corporation, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes products targeting inflammation, coagulopathies, and disorders of the central nervous system. Its clinical products include Omidria, which has completed two Phase III clinical trials for use during intraocular lens replacement, including cataract and other lens replacement surgery; OMS103 that is in Phase III clinical program for use during arthroscopic procedures, such as partial meniscectomy surgery; and OMS824, which is in Phase II clinical trial for the treatment of CNS disorders comprising schizophrenia and Huntington's disease. Its clinical programs also consist of OMS721 that is in Phase II clinical trial for the treatment of various complement-related diseases and disorders, including thrombotic microangiopathies; OMS405, which is in Phase II clinical trial for the treatment and prevention of addiction to substances of abuse; and OMS201 that has completed Phase 1/Phase 2 clinical trial for use during urological procedures, such as ureterscopy for removal of ureteral or renal stones. The company's preclinical products and development programs comprise OMS527 for the treatment of addiction and compulsive disorders, as well as for movement disorders, such as Parkinson's disease; and OMS616 for the control of blood loss during surgery, or resulting from trauma or other hyperfibrinolytic conditions. Its preclinical products also include G protein-coupled receptors platform for multiple disorders across therapeutic area; GPR17 for demyelinating disorders; and antibody platform for the discovery of monoclonal antibodies. Omeros Corporation was incorporated in 1994 and is based in Seattle, Washington.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Cable Thomas J.DirectorSep 02Sale15.075,00075,33057,067Sep 04 08:00 PM
Demopulos Peter A MDDirectorJun 24Buy16.206,15399,704181,220Jun 24 07:00 PM
Demopulos Gregory A MDChairman, CEO & PresidentMay 18Option Exercise0.9820,00019,6001,526,822May 19 05:49 PM
Kelbon Marcia S.VP Patent and General CounselMay 16Option Exercise0.983,7743,699126,024May 19 05:52 PM
Cable Thomas J.DirectorMar 03Sale12.765,00063,81067,067Mar 05 04:05 PM
CompanyOragenics Inc.
Market Cap37.66MEPS (ttm)-0.53
P/E-EPS this Y24.30%
Forward P/E-EPS next Y-
PEG-EPS past 5Y30.40%
P/S31.38EPS next 5Y-
P/B2.97EPS Q/Q37.50%
Dividend-Sales Q/Q50.00%
Insider Own2.30%Inst Own41.10%
Insider Trans6.52%Inst Trans-0.02%
Short Float0.05%EarningsNov 11
Analyst Recom1.00Target Price7.00
Avg Volume16.31K52W Range0.89 - 4.65
15-Oct-14 04:33PM3 Health Care Stocks Pushing The Sector Higher at TheStreet
15-Oct-14 04:33PM3 Drugs Stocks Pushing The Industry Higher at TheStreet
10-Sep-14 07:45AMOragenics Appoints Key Hires to Drive Lantibiotic Platform Growth and Expansion Business Wire
20-Aug-14 01:04PMORAGENICS INC Financials EDGAR Online Financials
07-Aug-14 04:08PMORAGENICS INC Files SEC form 10-Q, Quarterly Report EDGAR Online
11-Jun-14 06:39AMOragenics (OGEN) in Focus: Stock Adds 6% in Session Zacks
10-Jun-14 03:40PMExclusive: Oragenics CEO John Bonfiglio Talks Intrexon, Lantibiotics Benzinga
03-Jun-14 04:45PMORAGENICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws EDGAR Online
14-May-14 08:22AMOragenics (OGEN) Catches Eye: Stock Rises 9.7% Zacks
09-May-14 04:18PMORAGENICS INC Files SEC form 10-Q, Quarterly Report EDGAR Online
Oragenics, Inc. focuses on the discovery, development, and commercialization of various technologies associated with oral health, antibiotics, and other general health benefits. It develops and markets probiotic products comprising ProBiora3, an oral care probiotics that promote oral health for humans and pets under the Evora and ProBiora brands in approximately 13 countries worldwide. The company's ProBiora3 products include flavored probiotic tablets, such as EvoraPlus and EvoraKids for daily use by adults and children; EvoraPet for companion pets, including cats and dogs; and EvoraPro, a product for the dental office channel. Its product candidates consists of LPT3-04, a naturally occurring compound for weight loss; SMaRT Replacement Therapy, a topical treatment applied to the teeth to protect against tooth decay; and MU1140-S, an antibiotic product candidate in preclinical testing for healthcare-associated infections. Oragenics, Inc. offers its ProBiora3 products through direct-to-consumer channels, professional offices, and private label partnerships. The company was formerly known as Oragen, Inc. Oragenics, Inc. was founded in 1996 and is headquartered in Tampa, Florida.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BONFIGLIO JOHN NPresident and CEOAug 13Buy1.701,0001,705385,255Aug 13 04:06 PM
KOSKI FAMILY LP10% OwnerMar 28Sale3.052006101,041,723Mar 31 01:32 PM
DUNTON ALAN WDirectorMar 26Sale3.055,00015,25057,888Mar 27 10:21 AM
KOSKI FAMILY LP10% OwnerMar 26Sale3.084,33013,3231,041,923Mar 27 04:10 PM
KOSKI FAMILY LP10% OwnerMar 25Sale3.052,4007,3201,046,253Mar 27 04:10 PM
CompanyAltisource Portfolio Solutions S.A.
IndustryBusiness Services
Market Cap1.85BEPS (ttm)6.71
P/E12.59EPS this Y17.20%
Forward P/E9.24EPS next Y11.64%
PEG0.63EPS past 5Y68.70%
P/S1.91EPS next 5Y20.00%
P/B10.89EPS Q/Q79.20%
Dividend-Sales Q/Q59.10%
Insider Own0.30%Inst Own80.20%
Insider Trans13.91%Inst Trans1.28%
Short Float27.41%EarningsOct 23
Analyst Recom2.70Target Price123.50
Avg Volume310.07K52W Range83.37 - 171.00
22-Oct-14 03:00AMOcwen's Backdated Letters May Violate Consent Order at Bloomberg
21-Oct-14 02:24PMOcwen Dives On N.Y. Claims It Backdated Documents at Investor's Business Daily
21-Oct-14 12:59PMSHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Altisource Portfolio Solutions S.A. and Its Board of Directors and a Lead Plaintiff Deadline of November 7, 2014 Business Wire
17-Oct-14 10:32AMINVESTOR ALERT: Glancy Binkow & Goldberg LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Lawsuit Against Altisource Portfolio Solutions S.A. Business Wire
10-Oct-14 11:45AMAltisource Portfolio Solutions Schedules Third Quarter Conference Call GlobeNewswire
06-Oct-14 02:09PMUPCOMING DEADLINE: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Altisource Portfolio Solutions S.A. and Its Board of Directors and a Lead Plaintiff Deadline of November 7, 2014 -- ASPS GlobeNewswire
04-Oct-14 08:00AMSHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Altisource Portfolio Solutions SA to Contact Brower Piven Before the November 7, 2014 Lead Plaintiff Deadline in Class Action Laws GlobeNewswire
30-Sep-14 02:37PMUPCOMING DEADLINE: Levi & Korsinsky, LLP Notifies Investors of Class Action Against Altisource Portfolio Solutions S.A. and Its Board of Directors and a Lead Plaintiff Deadline of November 7, 2014 -- ASPS Marketwired
26-Sep-14 07:30PMFaruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Altisource Portfolio Solutions S.A. (ASPS) To Contact The Firm PR Newswire
26-Sep-14 06:45PMEQUITY ALERT: The Rosen Law Firm Reminds Altisource Portfolio Solutions SA Investors of Deadline for Securities Class Action -- ASPS GlobeNewswire
Altisource Portfolio Solutions S.A. operates as a marketplace and transaction solutions provider for the real estate, mortgage, and consumer debt industries in the United States. Its Mortgage Services segment offers services that span the mortgage and real estate lifecycle for loan servicers, originators, and investors in single family homes. This segment provides asset management services, which include property preservation, property inspection, real estate owned (REO) asset management, and REO brokerage; residential property valuation; title insurance services; origination management services; and default management services, such as non-legal processing and related services for the supervision of foreclosure, bankruptcy, and eviction attorneys. The company's Financial Services segment offers collection and customer relationship management services. This segment provides asset recovery management services, such as post-charge-off consumer debt collection; and customer care and early stage collections, insurance and claims processing, call center, and analytical support services. Its Technology Services segment offers REALSuite of software products consisting of REALServicing, an enterprise residential mortgage loan servicing product; REALTrans, an electronic business-to-business exchange that automates and simplifies the ordering, tracking, and fulfilling of mortgage services; REALRemit, an electronic invoicing and payment system; REALDoc, a management platform that extracts, stores, and generates correspondence; and Equator's Solutions platforms that are used a la carte or together as an end-to-end solution, as well as information technology infrastructure services. The company serves sub-prime servicers, utility companies, commercial banks, servicers, mortgage bankers, financial service companies, and hedge funds, as well as a government-sponsored enterprise. Altisource Portfolio Solutions S.A. was incorporated in 1999 and is headquartered in Luxembourg.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MUELLER-INEICHEN ROLANDDirectorAug 08Buy84.311,500126,46515,811Aug 11 04:27 PM
HYNES MARK J.President, Technology ServicesAug 04Buy87.201,00087,20015,460Aug 13 02:15 PM
Vatto TimoDirectorMay 22Buy102.9180082,32711,111May 23 01:52 PM
LINN W MICHAELDirectorMay 22Buy101.8197599,2654,494May 23 01:52 PM
LINN W MICHAELDirectorMay 13Buy106.651,000106,6453,519May 15 12:17 PM
1 2 3 4 5 6 next